Currency in USD
| Earnings estimate | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.05 | -0.09 | -0.29 | 0.03 |
| Low estimate | -0.05 | -0.09 | -0.33 | -0.1 |
| High estimate | -0.05 | -0.09 | -0.25 | 0.17 |
| Year ago EPS | -0.23 | -0.07 | -1.23 | -0.29 |
| Revenue estimate | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 28.3M | 27.21M | 107.74M | 116.44M |
| Low estimate | 28.3M | 26.9M | 107.71M | 112.3M |
| High estimate | 28.3M | 27.53M | 107.76M | 120.57M |
| Year ago sales | 20.26M | 23.05M | 76.7M | 107.74M |
| Sales growth (year/est) | 39.70% | 18.10% | 40.50% | 8.10% |
| Earnings history | 30/03/2022 | 29/06/2022 | 29/09/2022 | 30/12/2022 |
|---|
| Est. EPS | -0.3 | -0.2 | -0.21 | -0.08 |
| Actual EPS | -0.23 | -0.07 | -0.14 | -0.07 |
| Difference | 0.07 | 0.13 | 0.07 | 0.01 |
| Surprise % | 23.30% | 65.00% | 33.30% | 12.50% |
| EPS trend | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
|---|
| Current estimate | -0.05 | -0.09 | -0.29 | 0.03 |
| 7 days ago | -0.05 | -0.09 | -0.29 | 0.03 |
| 30 days ago | -0.05 | -0.09 | -0.29 | 0.03 |
| 60 days ago | -0.09 | 0 | -0.37 | -0.1 |
| 90 days ago | -0.09 | 0 | -0.37 | -0.1 |
| EPS revisions | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | MEDXF | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | 78.30% | N/A | N/A | N/A |
| Next qtr. | -28.60% | N/A | N/A | N/A |
| Current year | 76.40% | N/A | N/A | N/A |
| Next year | 110.30% | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
